Ticlopidine Hydrochloride CAS: 53885-35-1
MF: C14H14ClNS•HCl
MW: 300.25
A platelet aggregation inhibitor.

Ticlopidine Hydrochloride (CAS 53885-35-1)

Ticlopidine Hydrochloride | CAS 53885-35-1 is rated 5.0 out of 5 by 1.
  • y_2021, m_9, d_16, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.19
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_205861, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 106ms
  • REVIEWS, PRODUCT
loading
5
1
4
0
3
0
2
0
1
0
Application: Ticlopidine Hydrochloride is a platelet aggregation inhibitor
CAS Number: 53885-35-1
Purity: ≥99%
Molecular Weight: 300.25
Molecular Formula: C14H14ClNS•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).
loading

Ticlopidine hydrochloride is a platelet aggregation inhibitor capable of inducing apoptosis in various cancer cell lines by antagonizing the P2Y12 receptor, which is responsible for initiating the signal transduction that causes platelets to aggregate.


References

Chen WH, Yin HL, Chang YY et al. Kaohsiung J Med Sci. 13:589-97 (1997). Ma L, Elliott SN, Cirino G et al. Proc Natl Acad Sci U S A. 98:6470-5 (2001).

Physical State :
Solid
Solubility :
Soluble in methanol, water (4 mg/ml at 25° C), ethanol (1 mg/ml at 25° C), and DMSO (1 mg/ml at 25° C).
Storage :
Store at 4° C
Melting Point :
190° C
Boiling Point :
367.3° C at 760 mmHg (Predicted)
Refractive Index :
n20D 1.64 (Predicted)
IC50 :
P2 receptor: IC50 = ~2 µM; human platelet aggregation: IC50 = 1057 µM
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
RTECS :
XJ9089100
PubChem CID :
MDL Number :
MFCD00079606
EC Number :
258-837-4
SMILES :
C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Ticlopidine Hydrochloride (CAS 53885-35-1)  Product Citations

See how others have used Ticlopidine Hydrochloride (CAS 53885-35-1). Click on the entry to view the PubMed entry .

Citations 1 to 2 of 2 total

PMID: # 25939592  Kaneko, M.|Minematsu, T.|Yoshida, M.|Nishijima, Y.|Noguchi, H.|Ohta, Y.|Nakagami, G.|Mori, T.|Sanada, H.| et al. 2015. Wound Repair Regen. 23: 657-63.

PMID: # 25422175  Wang, W. et al. 2015. Chirality. 27: 170-6.

Citations 1 to 2 of 2 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 104ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Park MS; et al Park MS; et al. (PubMed ID: 26327247) determined that Ticlopidine Hydrochloride blocks the effect of angiogenic vascular endothelial growth factor by reducing the human umbilical vein endothelial cells, in frog embryos. -SCBT Publication Review
Date published: 2015-01-10
  • y_2021, m_9, d_16, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.19
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_205861, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 15ms
  • REVIEWS, PRODUCT